Nanomix Corp Asset Turnover Ratio (NNMX), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nanomix Corp  (NNMX)
 

Nanomix Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Dec 31 2022, Nanomix Corp has not recorded any assets.
Visit Nanomix Corp Balance sheet

Within sector Nanomix Corp achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2022 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NNMX Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Asset Change 8.43 % -66.38 % -77.38 % 2195.07 % 4451.51 %
Y / Y Revenue Change - - - - 12919.1 %
Asset Turnover Ratio (TTM) - - 0.1 - 0.14
NNMX's Total Ranking # # # # #
Seq. Asset Change -3.03 % 2.54 % -14.72 % 27.87 % -69.93 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




NNMX Company Profile • Back to NNMX Efficiency Comparisons • Compare NNMX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Foghorn Therapeutics Inc   0.04 $ 19.228  Millions$ 446.005  Millions
Stoke Therapeutics Inc   0.04 $ 12.405  Millions$ 287.765  Millions
Intellia Therapeutics Inc   0.04 $ 52.121  Millions$ 1,229.446  Millions
Celularity Inc   0.04 $ 17.975  Millions$ 425.430  Millions
Xoma Royalty Corporation  0.04 $ 6.027  Millions$ 149.974  Millions
Intellipharmaceutics International Inc   0.04 $ 0.066  Millions$ 1.660  Millions
Lexaria Bioscience Corp   0.04 $ 0.343  Millions$ 9.055  Millions
Longeveron Inc   0.04 $ 1.222  Millions$ 33.107  Millions
Streamex Corp   0.04 $ 0.286  Millions$ 7.814  Millions
Inovio Pharmaceuticals Inc   0.04 $ 15.044  Millions$ 411.353  Millions
Abeona Therapeutics Inc   0.04 $ 1.845  Millions$ 50.716  Millions
Old Ayala Inc   0.04 $ 0.692  Millions$ 19.175  Millions
Editas Medicine Inc   0.04 $ 19.712  Millions$ 562.323  Millions
Pliant Therapeutics Inc   0.03 $ 9.685  Millions$ 277.359  Millions
Igc Pharma Inc   0.03 $ 0.868  Millions$ 24.948  Millions
Caribou Biosciences Inc   0.03 $ 13.851  Millions$ 409.988  Millions
Nano X Imaging Ltd  0.03 $ 8.578  Millions$ 253.933  Millions
Bicycle Therapeutics Plc  0.03 $ 14.463  Millions$ 433.201  Millions
Talphera Inc   0.03 $ 1.771  Millions$ 55.975  Millions
Sonnet Biotherapeutics Holdings Inc   0.03 $ 0.257  Millions$ 8.327  Millions
Clearside Biomedical Inc   0.03 $ 1.327  Millions$ 43.448  Millions
Seer Inc   0.03 $ 15.493  Millions$ 507.881  Millions
Motus Gi Holdings Inc   0.03 $ 0.592  Millions$ 19.880  Millions
Yubo International Biotech Limited  0.03 $ 0.104  Millions$ 3.646  Millions
Fulcrum Therapeutics Inc   0.03 $ 6.342  Millions$ 222.493  Millions
Vyant Bio Inc   0.03 $ 0.666  Millions$ 24.396  Millions
Anavex Life Sciences Corp   0.03 $ 4.248  Millions$ 156.477  Millions
Beyondspring Inc   0.03 $ 1.351  Millions$ 50.608  Millions
Spyre Therapeutics Inc   0.03 $ 2.329  Millions$ 88.147  Millions
Lipocine Inc   0.03 $ 1.066  Millions$ 41.691  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.